Raju Reshma, O'Neil Luke, Kerr Charlotte, Lehri Burhan, Sarkar Sudipta, Soni Twinkle, Nguipdop-Djomo Patrick, Conan Anne, Tu Nguyen Dong, Hung Tran Thi Mai, Hay Melanie, Falconer Jane, Tomley Fiona, Blake Damer, Fournié Guillaume, Ajjampur Sitara Swarna Rao, Mangtani Punam, Stabler Richard
The Wellcome Trust Research Laboratory, Christian Medical College Vellore, Vellore, Tamil Nadu, India.
Transmission Biology Group, The Pirbright Institute, Woking, UK.
JAC Antimicrob Resist. 2024 Nov 26;6(6):dlae190. doi: 10.1093/jacamr/dlae190. eCollection 2024 Dec.
Non-typhoidal (NTS) commonly causes a self-limiting illness but invasive disease (iNTS) can be life-threatening. Antimicrobial resistance (AMR) increases the risk of mortality. This systematic review aimed to estimate the proportion of NTS isolated in those attending healthcare services, serovar burden, AMR, serovar-specific AMR, and case fatality rate (CFR) in India, Bangladesh, Sri Lanka and Vietnam.
The review included quantitative studies on NTS and AMR from 1980 to 2020 but excluded studies unrelated to humans or selected countries. Data were extracted from articles identified from Ovid SP, Web of Science, Wiley Cochrane Library, Elsevier Scopus and WHO Global Index Medicus. The Joanna Briggs Institute Critical Appraisal Tools Checklist for Prevalence Studies was used for risk-of-bias assessment. Meta-analyses were performed for the proportion of NTS isolated, the proportion of specific serovars isolated, percentage of AMR and CFR.
Six thousand and twenty-six isolates (79 serovars) were identified from 73 studies, with serovar Typhimurium being the most common. Of the 73 selected studies, 46% were hospital/laboratory surveillance studies, examining the aetiology of invasive or non-invasive infections. The pooled proportion estimate for non-iNTS was 2.1% (95% CI: 1.2%-3.2%) and for iNTS was 0.3% (95% CI: 0.1%-0.5%). The pooled CFR was 14.9% (95% CI: 4.0%-29.6%). Pooled resistance estimates for ampicillin, ceftriaxone, chloramphenicol, ciprofloxacin, co-trimoxazole, nalidixic acid and azithromycin were calculated. MDR iNTS was less prevalent in India [22.3% (95% CI: 0.0%-66.8%)] than in Vietnam [41.2% (95% CI: 33.6%-49.3%)]. Heterogeneity of studies was high as the majority were observational surveillance studies.
Despite data scarcity in some countries, this review highlights the continued contribution of NTS infection to disease burden, compounded by high AMR rates.
非伤寒沙门氏菌(NTS)通常引起自限性疾病,但侵袭性疾病(iNTS)可能危及生命。抗菌药物耐药性(AMR)会增加死亡风险。本系统评价旨在估计在印度、孟加拉国、斯里兰卡和越南接受医疗服务的人群中分离出的NTS比例、血清型负担、AMR、血清型特异性AMR以及病死率(CFR)。
该评价纳入了1980年至2020年关于NTS和AMR的定量研究,但排除了与人类或选定国家无关的研究。数据从Ovid SP、科学网、威利考克兰图书馆、爱思唯尔Scopus和世卫组织全球医学索引中识别出的文章中提取。采用乔安娜·布里格斯研究所患病率研究批判性评价工具清单进行偏倚风险评估。对分离出的NTS比例、特定血清型分离比例、AMR百分比和CFR进行荟萃分析。
从73项研究中鉴定出6026株菌株(79种血清型),其中鼠伤寒血清型最为常见。在选定的73项研究中,46%为医院/实验室监测研究,检查侵袭性或非侵袭性感染的病因。非iNTS的合并比例估计为2.1%(95%CI:1.2%-3.2%),iNTS为0.3%(95%CI:0.1%-0.5%)。合并CFR为14.9%(95%CI:4.0%-29.6%)。计算了氨苄西林、头孢曲松、氯霉素、环丙沙星、复方新诺明、萘啶酸和阿奇霉素的合并耐药估计值。多重耐药iNTS在印度的患病率[22.3%(95%CI:0.0%-66.8%)]低于越南[41.2%(95%CI:33.6%-49.3%)]。由于大多数研究为观察性监测研究,研究的异质性较高。
尽管一些国家数据匮乏,但本评价强调了NTS感染对疾病负担的持续影响,高AMR率使其进一步加重。